Adaptive Biotechnologies Market Cap

Adaptive Biotechnologies has a market cap or net worth of $2.29 billion as of March 9, 2026. Its market cap has increased by 86.01% in one year.

Market Cap

2.29B

Enterprise Value

2.20B

1-Year Change

86.01%

Ranking

#1904

Market Cap Chart

Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $2.29B, a decrease of -52.04%. That is a compound annual growth rate of -10.39%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	2.29B	-7.71%
Dec 31, 2025	2.48B	180.23%
Dec 31, 2024	884.74M	24.72%
Dec 29, 2023	709.39M	-35.07%
Dec 30, 2022	1.09B	-72.41%
Dec 31, 2021	3.96B	-51.03%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wave Life Sciences	2.47B
Dyne Therapeutics	2.45B
Tango Therapeutics	2.42B
Immunome	2.38B
Disc Medicine	2.33B
Ocular Therapeutix	2.24B
Day One Biopharmaceuticals	2.19B
Zai Lab	2.19B

Market Cap Rankings